政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/65774
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  全文笔数/总笔数 : 113648/144635 (79%)
造访人次 : 51630468      在线人数 : 551
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    请使用永久网址来引用或连结此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/65774


    题名: 增進台灣國家衛生研究院授權活動成效之研究 -以美國國家衛生研究院授權活動為例
    Research to Increase Taiwan National Health Research Institutes Licensing Performance by Comparing The Licensing Practice of United States National Institutes of Health
    作者: 丘耀華
    Hew, Yaohua
    贡献者: 陳桂恒
    Chan, Keith
    丘耀華
    Hew, Yaohua
    关键词: 授權績效
    資訊公開法
    FOIA
    NIH
    NHRI
    國家衛生研究院
    Licensing performance
    Freedom of Information
    NIH
    NHRI
    FOIA
    日期: 2013
    上传时间: 2014-05-01 15:21:19 (UTC+8)
    摘要: 1980年,在美國拜杜法案(Bayh-Dole Act)通過以後,政府補助研發成果從原屬於國家財產,下放歸屬權於研發單位。因此研發單位可自行管理並將研發成果授權至產業界,將研發成果商品化,此過程稱之為「技術移轉」。技術移轉是一個非常細膩且複雜的過程,有許多因素會左右技術移轉的成敗,其中包括:技術之品質、法律限制、政策因素、產業需求和資訊流通等因素。技術移轉將可以使研發成果商品化, 有助於提升政府稅收和權利金收入,並且推動科學發展和增加就業機會,為國家創造經濟收入。

    本研究旨探如何提升政府補助國立生醫研究單位-台灣國家衛生研究院(NHRI)之授權績效。本研究將採用美國國家衛生研究院(NIH)之授權績效和授權執行方式當參考指標。為了得到精準和可信的數據,本研究僅截取官方之年報和網站的資料。與此同時,本研究末將會提供如何提升授權績效之建議。

    此研究發現就2010年而言,NIH和NHRI之授權績效可謂旗鼓相當。儘管台灣立法規定「政府資訊公開法」,此研究發現台灣國家衛生研究院有選擇性的發表其授權績效的跡象。由於政府所有開銷均從其預算而來,而政府預算部分自人民納稅所得,因此監督政府績效是普羅大眾的基本權利。人民有權監督,並且要求政府就其管理、執行成效做出解釋。然而,台灣國家衛生研究院之資訊不透明舉動,限制了人民監督的權利,此舉將會因缺乏監督而惡性循環的造成授權績效更為疲弱。此外,此研究亦發現較少的授權契約種類、授權策略在地化、研發成果披露之不明確性、智慧財產委員會專利申請和授權策略失衡是造成NHRI授權成果疲弱的因素。
    Since the passage of U.S. Bayh-Dole Act in 1980, government-funded research inventions were no longer considered as government property. Invention could be patented and be licensed to industry through the process of commercialization for revenue return. Commercialization will create revenue in the form of royalty and taxes to the government, further driving scientific improvement and increase job opportunities.

    Technology commercialization is a very delicate process and there are a lot of factors that might alter the success, including but not limited to i) the quality of invention, ii) legislation restriction, iii) policy incentives, iv) industry interest, v) availability of information and etc. If managed properly, technology commercialization could bring high value to the academic institutes that developed an invention, to government that financially support academic research and to general public that could benefit from the invention itself.

    This study intends to identify the factors of the weak licensing performance in Taiwan government-funded national biomedical research organization, National Health Research Institute (NHRI). To evaluate the licensing performance of NHRI, this study will compare the licensing performance of NHRI with National Institute of Health (NIH) in the United States. To get accurate and formal data, this study will mainly retrieve data from official annual report and website. By comparing the practice of technology commercialization process of both institutes, this study could suggest possible flaws in NHRI’s licensing process in comparison to NIH. At the same time, this study will give suggestions to achieve a better licensing performance.

    This study concluded that both institute performed equally in FY 2010, but it has been noticed that NHRI were selectively in disclosing its licensing performance statistics and it is difficult to retrieve general information from NHRI, despite the availability of Freedom of Government Information Law (Taiwan). It’s the basic right for the general public to be able to supervise and surveillance a government agency’s performance as it utilizes the taxes contributed by a citizen in a country. The limitation of information disclosure by NHRI has made it difficult for general public supervise its licensing performance, of which might further contribute to even weaker licensing performance due to lack of supervision. This research also concluded that few options of licensing contracts, localization in licensing strategy, confusion in technology disclosure, possible misalignment of patenting & licensing strategy of the IP Management Committee contributes to weak licensing performance in the NHRI.
    參考文獻: Books:
    Alasdair Roberts (2006), Blacked Out: Government Secrecy in the Information Age, Cambridge.

    Sherman, B.; Bently, L. (1999). The making of modern intellectual property law: the British experience, 1760–1911. Cambridge University Press. p. 207. ISBN 9780521563635

    Athan G. Theoharis (1998). A Culture of Secrecy: The Government Versus the People’s Right to Know. Kansas: University Press of Kansas.

    Loise, V., Stevens A.J., (December 2010), The Bayh-Dole Act Turns 30, Les Nouvelles December 2010: 185-94.

    Papers/Publications:
    A Healthy Intramural Program (1988), Institute of Medicine.

    Congressional Budget Office (October 2006), p.3, Research and Development in the Pharmaceutical Industry.

    Dorsey, E.R., Roulet, J., Thompson J.P., et al., Funding of US Biomedical Research, 2003-2008 (January 13, 2010), Journal of the American Medical Association, vol. 303, no. 2, pp. 137-143.

    Lemley, M.A., Rational Ignorance at the Patent Office (February 2001). Northwestern University Law Review, Vol. 95, No. 4, 2001.

    Office of Technology Assessment (February 1993), p.201, Pharmaceutical R&D: Costs, Risks and Rewards.

    Henderson, R., Jaffe, A., Trajtenberg, M., (March, 1999), Universities as a source of commercial technology: A detailed analysis of university patenting, 1965-1988, NBER Working Paper, No. 5068.

    United State General Account Office (1986), Patent Policy: Universities’ Research Efforts Under Public Law.

    Internet Publications:
    2013 Biopharmaceutical Research Industry Profile, p40, (July, 2013), Pharmaceutical Research and Manufacturers of America (PhRMA), Retrieved from http://phrma.org/sites/default/files/pdf/PhRMA%20Profile%202013.pdf

    A Short History of the National Institute of Health (n.d.), National Institute of Health, Retrieved from http://history.nih.gov/exhibits/history/index.html

    About the FOIA (n.d.), The United States Department of Justice, Retrieved from http://www.justice.gov/oip/about-foia.html

    Annual Report FY 2008 (2008), NIH Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/sites/default/files/documents/pdfs/AR2008.pdf

    Annual Report FY 2009 (2009), NIH Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/sites/default/files/documents/pdfs/AR2009.pdf

    Annual Report FY 2010 (2010), NIH Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/sites/default/files/documents/pdfs/AR2010.pdf

    Annual Report FY 2011 (2011), NIH Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/sites/default/files/documents/pdfs/AR2011.pdf

    Annual Report FY 2012 (2012), NIH Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/sites/default/files/documents/pdfs/AR2012.pdf

    Association of University Technology Manager (2012). AUTM U.S. Licensing Activity Survey FY2012 Highlights. Retrieved from http://www.autm.net/AM/Template.cfm?Section=FY2012_Licensing_Activity_Survey&Template=/CM/ContentDisplay.cfm&ContentID=11435

    Biomedical Research and Development Price Index (BRDPI): Fiscal Year 2012 Update and Projections for FY 2013-FY 2018 (January 2013), Department of Health and Human Services, Retrieved from

    Budget Process Calendar (n.d.), National Institute of Health, Retrieved from http://officeofbudget.od.nih.gov/pdfs/FY14/Budget%20Process%20(Timeline%20Chart)-NEW1a.pdf

    Countries Not Members of the Patent Cooperation Treaty (PCT) (October 9, 2012), Neustel Law Offices, Retrieved from http://www.patent-ideas.com/international-patents/countries-not-members-of-pct.aspx

    Electronic Code of Federal Regulations (November, 2013), U.S. Government Printing Office, Retrieved from http://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&SID=b1b3f0363cc8f316c1f41b2628e8e005&rgn=div8&view=text&node=37:1.0.4.13.1.0.218.14&idno=37

    Forms and Model Agreements (n.d.), NIH Office of Intramural Research & Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/forms-model-agreements#INTER

    Freedom of Information Act – Memorandum for The Heads of Executive Departments and Agencies (n.d.), the WHITEHOUSE, Retrieved from http://www.whitehouse.gov/the_press_office/FreedomofInformationAct/

    Government Transparency (n.d.), The United States Department of Justice, Retrieved from http://www.justice.gov/oip/government-transparency.html

    Gross Domestic Product (GDP) Price Index (n.d.), NIH Office of Budget, Retrieved from http://officeofbudget.od.nih.gov/gbiPriceIndexes.html

    HHS Lights Up The World (n.d.), National Institutes of Health Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/service/hhs-lights-world
    http://officeofbudget.od.nih.gov/pdfs/FY13/BRDPI/BRDPI_Proj_Jan_2013_Final.pdf

    Indicators of Science and Technology (FY 2012) (n.d.), Taiwan National Science Council, Retrieved from https://nscnt12.nsc.gov.tw/WAS2/technology/AsTechnologyDataIndex.aspx

    iPhone/iPad App (n.d.), National Institutes of Health Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/service/iphoneipad-app

    Justice Brandies, L.D., (n.d.), Brandies University, Retrieved from http://www.brandeis.edu/legacyfund/bio.html

    Kelly Burke (12 Feb, 2013), Report Finds Average US Patent Cost US$ 374,000 In 2012, Intellectual Property Watch, Retrieved from http://www.ip-watch.org/2013/02/12/first-patent-value-quotient-report-shows-average-price-paid-for-issued-us-patents/?utm_source=post&utm_medium=email&utm_campaign=alerts

    Licensing (n.d.), NIH Office for Technology Transfer, Retrieved from http://www.ott.nih.gov/licensing

    Licensing and Patenting Managers, NIH Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/staff-directory/lpms

    Licensing FAQs (n.d.), NIH Office for Technology Transfer, Retrieved from http://www.ott.nih.gov/licensing-faqs

    Licensing Process (n.d.), NIH Office for Technology Transfer, Retrieved from http://www.ott.nih.gov/licensing-process

    Main Science and Technology Indicators (MSTI) 2012/1 (n.d.), Organization for Economic Co-operation and Development (OECD), Retrieved from http://www.oecd.org/sti/msti.htm

    Measuring the Economic Impact of IP Systems (2007), World Intellectual Property Organization, Retrieved from http://www.wipo.int/portal/en/news/2007/article_0032.html

    Mission (n.d.), National Institutes of Health, Retrieved from http://www.nih.gov/about/mission.htm

    Mission (n.d.), NIH Technology Transfer and Incubation Center, Retrieved from http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do?status=Show_Data&uid=20110617851073820000

    NIH FY 2013 Budget (2013), Department of Health and Human Services National Institutes of Health, Retrieved from http://officeofbudget.od.nih.gov/pdfs/FY13/FY2013_Overview.pdf

    NIH Intramural Research at the Threshold of a New Era (September 2009), NIH Office of Intramural Research. Retrieved from http://sourcebook.od.nih.gov/oir/IRP_transition.pdf

    NIH Start-Up Exclusive License Agreements (n.d.), NIH Office of Intramural Research and Office of Technology Transfer, http://www.ott.nih.gov/nih-start-exclusive-license-agreements

    Non-Profit License Agreement – Summary (n.d.), National Institutes of Health Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/node/non-profit-license-agreement-summary

    Oppedahl, C., (June 1999), Filing A PCT Application May Lead To A Faster, Cheaper US Patent, Oppedahl & Olson LLP, Retrieved from http://www.oppedahl.com/pubs/pctfaster.htm

    OTT Statistics (n.d.), NIH Office of Intramural Research and Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/ott-statistics

    Overview (n.d.), National Health Research Institute, Retrieved from http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do?status=Show_Data&uid=20110617146947300000

    Patents: Frequently Asked Questions (n.d.), World Intellectual Property Organization, Retrieved from http://www.wipo.int/patentscope/en/patents_faq.html#protection

    PCT – The International Patent System (n.d.), WIPO, Retrieved from http://www.wipo.int/pct/en/

    Peptide Inhibitor of p38 Mapk Signaling for the Treatment of Inflammatory Autoimmune Diseases and Inflammatory Cancers(October 2013), NIH Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/technology/e-281-20120

    Price Index for Gross Domestic Product (January, 2013), NIH Office of Budget, Retrieved from http://officeofbudget.od.nih.gov/pdfs/FY14/GDPINDEX_Values_for_2012_2023.pdf

    Protecting Innovations by Utility Models (n.d.), WIPO, Retrieved from http://www.wipo.int/sme/en/ip_business/utility_models/utility_models.htm

    Royalty (n.d.), National Institutes of Health Office of Technology Transfer, Retrieved from http://www.ott.nih.gov/royalty

    Smith, P.W., The National Institutes of Health (NIH): Organization, Funding, and Congressional Issues (March 16, 2011), Congressional Research Service, Retrieved from www.crs.gov

    The Federal Advisory Committee Act (n.d.), U.S. General Services Administration, Retrieved from http://www.gsa.gov/portal/content/100916

    The Freedom of Information Act (1996), USDOJ, Retrieved from http://www.justice.gov/oip/foia_updates/Vol_XVII_4/page2.htm

    The Knowledge Based Economy (1996), Organization of Economic Co-operation and Development, Retrieved from http://www.oecd.org/sti/sci-tech/1913021.pdf

    What is the IRP? (n.d.), National Institute of Health Intramural Research Program, Retrieved from http://irp.nih.gov/about-us/what-is-the-irp

    What is the NIH Intramural Research Program? (n.d.), National Institute of Health, Retrieved from http://aids2012.oar.nih.gov/faqsnih.html#accomplishments

    What is the PCT? (Jun 8, 2011), Hawk IP Dashboard, Retrieved from http://www.hawkip.com/advice/what-is-the-pct

    WIPO Intellectual Property Handbook (n.d.), p.3, World Intellectual Property Organization, Retrieved from http://www.wipo.int/export/sites/www/about-ip/en/iprm/pdf/ch1.pdf

    WWI and the Ransdell Act of 1930 (n.d.), National Institutes of Health, Retrieved from http://history.nih.gov/exhibits/history/docs/page_04.html

    Personal Communication:
    Richard Rodriguez (Director, Division of Technology Development & Transfer), rodrigr@mail.nih.gov, personal communication, Jan 2, 2014.

    Richard Rodriguez (Director, Division of Technology Development & Transfer), rodrigr@mail.nih.gov, personal communication, Jan 3, 2014.

    Officer S, sxxx9@nhri.org.tw, personal communication, December 11, 2013

    Cases:
    Eli Lilly & Co. v. Barr Laboratories Inc., 251 F.3d 955, 963, 58 USPQ2d 1865, 1874 (Fed. Cir. 2001)
    描述: 碩士
    國立政治大學
    科技管理與智慧財產研究所
    100361019
    102
    資料來源: http://thesis.lib.nccu.edu.tw/record/#G0100361019
    数据类型: thesis
    显示于类别:[科技管理與智慧財產研究所] 學位論文

    文件中的档案:

    档案 大小格式浏览次数
    101901.pdf6303KbAdobe PDF2788检视/开启


    在政大典藏中所有的数据项都受到原著作权保护.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈